The FDA panel strongly supports the approval of qnexa, a weight-loss drug from vivus
-
Last Update: 2012-02-23
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: China Council for the promotion of drugs 2012-02-23 according to the street report, experts from non regulatory agencies gave strong support to vivus for FDA approval of its weight-loss drugs, and experts voted 20:2 on the afternoon of the 22nd to approve qnexa's listing in the United States The FDA's decision on April 17 to approve vivus, a drug developer based in mountain view, California, comes after a vote by the endocrine and Metabolic Drugs Advisory Board If approved, qnexa will be the first FDA approved new oral weight-loss drug in more than a decade As you know, FDA does not have to follow the panel's recommendations, but it often does.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
